Feedback plc exercise of options notification

Feedback plc (AIM: FDBK), the medical imaging software company, received notification of an exercise of options over 1.6 million new ordinary shares by an employee under its EMI share option scheme. The exercise price of the options is 1.25 pence each.

The New Ordinary Shares will rank pari passu with the existing ordinary shares and application will be made for the New Ordinary Shares to be admitted to trading on AIM (“Admission”). It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence by 8.00 a.m. on 15 July 2015 (“Admission”)

Following Admission the Company will have a total issued share capital of 203,673,857 ordinary shares with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority’s Disclosure and Transparency Rules.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    DirectorsTalk

    More articles like this

    Feedback Plc

    Feedback plc has sold Stone Checker Software

    Feedback plc (AIM: FDBK), the medical imaging software company has told DirectorsTalk that it has agreed to sell its 50% equity interest in Stone Checker Software Ltd (‘Stone Checker’) to Free Association Books Limited, a company

    Feedback Plc

    Feedback plc MOU with Alliance Medical Group to integrate TexRAD

    Feedback plc (AIM: FDBK), the medical imaging software company, has told DirectorsTalk that it has signed a Memorandum of Understanding with Alliance Medical Group with the intention of integrating Feedback’s TexRAD texture analysis software into Alliance’s lung

    DirectorsTalk

    Feedback plc Chairmans Statement, Tom Charlton said

    Feedback plc Chairmans Statement, Tom Charlton said: “We are pleased to present the results for the year ended 31 May 2015. These are the first full year results to include the trading of the two medical